Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Neurotensinergic System: A Target for Cancer Treatment
Manuel Lisardo Sánchez, Rafael Coveñas
Current Medicinal Chemistry (2021) Vol. 29, Iss. 18, pp. 3231-3260
Closed Access | Times Cited: 13

Showing 13 citing articles:

Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions
Priya Jayachandran, Francesca Battaglin, Carly Strelez, et al.
Oncogene (2023) Vol. 42, Iss. 9, pp. 627-637
Open Access | Times Cited: 28
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies
Manuel Lisardo Sánchez, Francisco D. Rodríguez, Rafael Coveñas
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9962-9962
Open Access | Times Cited: 23
The Galaninergic System: A Target for Cancer Treatment
Manuel Lisardo Sánchez, Rafael Coveñas
Cancers (2022) Vol. 14, Iss. 15, pp. 3755-3755
Open Access | Times Cited: 27
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families
Manuel Lisardo Sánchez, Francisco D. Rodríguez, Rafael Coveñas
Cancers (2023) Vol. 15, Iss. 6, pp. 1694-1694
Open Access | Times Cited: 11
N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake
Sacha Bodin, Tyrillshall S. T. Damiana, Santo Previti, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment
Francisco D. Rodríguez, Manuel Lisardo Sánchez, Rafael Coveñas
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8656-8656
Open Access | Times Cited: 9
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant
Rafael Coveñas, Francisco D. Rodríguez, Prema Robinson, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15936-15936
Open Access | Times Cited: 8
Structural and Functional Diversity of Animal Toxins Interacting With GPCRs
Anne-Cécile van Baelen, Philippe Robin, Pascal Kessler, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 13
Involvement of the Opioid Peptide Family in Cancer Progression
Manuel Lisardo Sánchez, Francisco D. Rodríguez, Rafael Coveñas
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1993-1993
Open Access | Times Cited: 4
Deciphering Mechanisms of Action of Sortilin/Neurotensin Receptor-3 in the Proliferation Regulation of Colorectal and Other Cancers
Jean Mazella
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11888-11888
Open Access | Times Cited: 4
Peptidergic G-Protein-Coupled Receptor Signaling Systems in Cancer: Examination of Receptor Structure and Signaling to Foster Innovative Pharmacological Solutions
Francisco D. Rodríguez, Rafael Coveñas
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 801-824
Open Access
Peptidergic Systems as Antitumor Targets: A Right Direction to Fight Cancer?
Francisco D. Rodríguez, Rafael Coveñas
Cancers (2023) Vol. 15, Iss. 20, pp. 4975-4975
Open Access
Physiological and Pathological Roles of NTSR2 in Several Organs and Diseases (Review)
Yuting Yang, Wenxin Zhang, Kun Wei, et al.
Protein and Peptide Letters (2023) Vol. 31, Iss. 1, pp. 3-10
Open Access
Page 1

Scroll to top